BR0208655A - Composição farmacêuticas - Google Patents
Composição farmacêuticasInfo
- Publication number
- BR0208655A BR0208655A BR0208655-7A BR0208655A BR0208655A BR 0208655 A BR0208655 A BR 0208655A BR 0208655 A BR0208655 A BR 0208655A BR 0208655 A BR0208655 A BR 0208655A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- ascomycin
- prevention
- reduction
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
"COMPOSIçõES FARMACêUTICAS". A invenção refere-se a composições farmacêuticas contendo uma ascomicina em forma dissolvida e um derivado de celulose farmaceuticamente aceitável para prevenção ou redução do crescimento de cristal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0108498.7A GB0108498D0 (en) | 2001-04-04 | 2001-04-04 | Organic Compounds |
PCT/EP2002/003694 WO2002080978A2 (en) | 2001-04-04 | 2002-04-03 | Pharmaceutical compositions comprising ascomycin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208655A true BR0208655A (pt) | 2004-03-02 |
Family
ID=9912264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208655-7A BR0208655A (pt) | 2001-04-04 | 2002-04-03 | Composição farmacêuticas |
Country Status (13)
Country | Link |
---|---|
US (3) | US20040171599A1 (pt) |
EP (1) | EP1377315B1 (pt) |
JP (1) | JP4927310B2 (pt) |
CN (2) | CN100358580C (pt) |
AT (1) | ATE350064T1 (pt) |
AU (1) | AU2002310920A1 (pt) |
BR (1) | BR0208655A (pt) |
CA (1) | CA2443235C (pt) |
DE (1) | DE60217315T2 (pt) |
GB (1) | GB0108498D0 (pt) |
HK (1) | HK1061647A1 (pt) |
PT (1) | PT1377315E (pt) |
WO (1) | WO2002080978A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004212264B9 (en) * | 2003-02-17 | 2009-11-26 | Cipla Limited | Pharmaceutical patch |
US20040185093A1 (en) * | 2003-03-18 | 2004-09-23 | Szymczak Christopher E. | Compositions containing sucralose |
RU2375044C2 (ru) | 2004-04-08 | 2009-12-10 | Новартис Аг | Пимекролимусная пенная композиция, включающая гексиленгликоль, необязательно олеиловый спирт, диметилизосорбид и/или триглицериды со средними цепями |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
GB0508827D0 (en) * | 2005-04-29 | 2005-06-08 | Novartis Ag | Cosmeceutical composition |
US9855243B2 (en) | 2013-10-30 | 2018-01-02 | Qurient Co., Ltd. | Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation |
KR101462474B1 (ko) * | 2013-10-30 | 2014-11-19 | 주식회사 큐리언트 | 질레우톤 크림 제형의 국소용 항염증 약학적 조성물 |
EP3294294A4 (en) * | 2015-05-08 | 2019-01-02 | Vivus, Inc. | Compositions and methods for the treatment or prevention of pulmonary hypertension |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4127647A (en) * | 1975-04-08 | 1978-11-28 | Meiji Seika Kaisha, Ltd. | Process for preparation of stable amorphous macrolide antibiotic solids |
GB8608080D0 (en) * | 1986-04-02 | 1986-05-08 | Fujisawa Pharmaceutical Co | Solid dispersion composition |
DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
PH31204A (en) * | 1990-11-02 | 1998-05-05 | Fujisawa Pharmaceutical Co | Pharmaceutical composition. |
IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
AU714254B2 (en) * | 1994-10-26 | 1999-12-23 | Novartis Ag | Pharmaceutical compositions |
WO1999049863A1 (fr) * | 1998-03-26 | 1999-10-07 | Fujisawa Pharmaceutical Co., Ltd. | Preparations a liberation prolongee |
JP3732525B2 (ja) * | 1998-04-27 | 2006-01-05 | アステラス製薬株式会社 | 医薬組成物 |
GB9817064D0 (en) * | 1998-08-05 | 1998-10-07 | Fujisawa Pharmaceutical Co | New use |
AUPR529701A0 (en) * | 2001-05-28 | 2001-06-21 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical composition |
-
2001
- 2001-04-04 GB GBGB0108498.7A patent/GB0108498D0/en not_active Ceased
-
2002
- 2002-04-03 EP EP02735219A patent/EP1377315B1/en not_active Expired - Lifetime
- 2002-04-03 AU AU2002310920A patent/AU2002310920A1/en not_active Abandoned
- 2002-04-03 PT PT02735219T patent/PT1377315E/pt unknown
- 2002-04-03 CN CNB2005100555523A patent/CN100358580C/zh not_active Expired - Fee Related
- 2002-04-03 WO PCT/EP2002/003694 patent/WO2002080978A2/en active IP Right Grant
- 2002-04-03 AT AT02735219T patent/ATE350064T1/de active
- 2002-04-03 BR BR0208655-7A patent/BR0208655A/pt not_active IP Right Cessation
- 2002-04-03 US US10/473,782 patent/US20040171599A1/en not_active Abandoned
- 2002-04-03 CN CNB028079108A patent/CN1226047C/zh not_active Expired - Fee Related
- 2002-04-03 DE DE60217315T patent/DE60217315T2/de not_active Expired - Lifetime
- 2002-04-03 JP JP2002579016A patent/JP4927310B2/ja not_active Expired - Fee Related
- 2002-04-03 CA CA2443235A patent/CA2443235C/en not_active Expired - Fee Related
-
2004
- 2004-06-28 HK HK04104625A patent/HK1061647A1/xx not_active IP Right Cessation
-
2007
- 2007-07-24 US US11/880,803 patent/US20070298058A1/en not_active Abandoned
-
2011
- 2011-05-23 US US13/113,331 patent/US20110224246A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002310920A1 (en) | 2002-10-21 |
EP1377315A2 (en) | 2004-01-07 |
CA2443235A1 (en) | 2002-10-17 |
GB0108498D0 (en) | 2001-05-23 |
US20040171599A1 (en) | 2004-09-02 |
JP4927310B2 (ja) | 2012-05-09 |
PT1377315E (pt) | 2007-02-28 |
HK1061647A1 (en) | 2004-09-30 |
CN1501814A (zh) | 2004-06-02 |
WO2002080978A3 (en) | 2003-10-30 |
US20110224246A1 (en) | 2011-09-15 |
EP1377315B1 (en) | 2007-01-03 |
DE60217315D1 (de) | 2007-02-15 |
US20070298058A1 (en) | 2007-12-27 |
CN100358580C (zh) | 2008-01-02 |
DE60217315T2 (de) | 2007-05-31 |
ATE350064T1 (de) | 2007-01-15 |
CN1226047C (zh) | 2005-11-09 |
CA2443235C (en) | 2011-03-15 |
JP2004525169A (ja) | 2004-08-19 |
WO2002080978A2 (en) | 2002-10-17 |
CN1679962A (zh) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004078712A3 (en) | Isoquinoline derivatives and methods of use thereof | |
AU2001263229A1 (en) | Compositions and methods for administration of pharmacologically active compounds | |
MXPA04002167A (es) | Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
HUP0100156A2 (hu) | Foszfolipáz-A2 inhibitor hatású indolszármazékok és alkalmazásuk gyógyászati készítmények előállítására | |
EE200100487A (et) | Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena | |
MY139446A (en) | Novel quinoline derivatives | |
DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2000055124A3 (en) | Novel compounds and compositions as protease inhibitors | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
DK1187803T3 (da) | Amorfe salpetersyreestere og deres farmaceutiske sammensætninger | |
MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
BR0208655A (pt) | Composição farmacêuticas | |
DE60026491D1 (de) | Melagatran zur behandlung von entzündungen | |
IL153540A0 (en) | THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | |
BG102661A (en) | Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors | |
ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
TW200503703A (en) | Pharmaceutical compositions | |
AU2001252419A1 (en) | Thrombin inhibitors | |
DE60226313D1 (de) | Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA.INT.CI.461K 47/38, A61K 31/436, A61P 37/06 Ipc: A61K 47/38 (2011.01), A61K 31/436 (2011.01), A61P |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014. |